To some, cannabis and exercise may seem like an unlikely pairing. But those in the know understand that cannabis in its various forms can serve as a great pre, during, or post-workout supplement. These Top 5 insights from BDS Analytics counter the “lazy stoner” stereotype and show that cannabis often is a welcome addition to Consumers’ workout routines.
CBD: it spans product categories, retail channels, regulatory landscapes – and even species. Last month’s webinar covered the current cannabinoid market as it relates to pain management as well as pet care, both within the dispensary channel (CBD from marijuana) and in the general retail market (hemp-derived CBD). While pain management and pet care might seem like disparate angles from which to talk about cannabinoids, they actually do have some common ground. The wellness market is booming, as consumers’ approach to health care shifts; similarly, the pet industry has grown consistently as pets take on an increasingly heightened role in the American household. Both cannabinoid-based pain and pet products cross retail channels, with availability in medical and adult-use dispensaries as well as across general market retail channels. And, across pain management and pet care, cannabinoid-based products are a welcome supplement (or alternative) to other forms of medical or wellness-based solutions. Here we’ll look at some of the main takeaways from the webinar – but for the full story, you can watch the presentation and download the deck here.
We’re in no rush to say goodbye to summer, but, as we head into Labor Day weekend, let’s review how the cannabis industry has fared during Labor Day weekends past and other key summer holiday periods:
Our August webinar, Pet, Pain, and CBD: The Many Applications of Cannabinoid Products is coming up this week. Here is some of what you can expect to learn – be sure to tune in on Thursday for the full story. Register here: http://bit.ly/2MRJQbU
Inspired by the Cannabis Intelligence Briefing Series Report:
As cannabis products and delivery systems continue to evolve, infused beverages are rapidly moving to the forefront– most recently marked by the announced partnership between Arizona Beverages and Dixie Brands. As of September 1, 2019, BDS Analytics market data reports 107 beverage brands in the legal dispensary channel (up from 69 in Q2 of 2018) across CA, CO, OR, AZ, and NV and BDS Analytics predicts beverage sales in the regulated dispensary channel to reach $1 billion by 2022. Here are the Top 5 canna-beverage facts from BDS Analytics:
Cannabis Ingestibles cover a lot of ground, including everything from pills to slices of pie to bottles of THC-infused cold-brewed coffee. But one style of ingestible dominates the market: the gummy.
Consumer spending on legal cannabis worldwide reached $10.9 billion in 2018. This number is especially significant considering the variables at play: the California market transition from lightly regulated medical-only to fully regulated adult-use; the maturation of first-in, adult-use markets in Colorado and Washington; and the lackluster rollout of legal adult-use cannabis in Canada. As legalization continues to spread, the global market is expected to grow at a compound annual growth rate (CAGR) of 24% between the end of 2018 and 2024, reaching $40.6 billion. So yes, the worldwide cannabis market will hit a staggering $40+ billion within 5 years.
Whether or not you keep up with the cannabis industry, you’ve likely heard the term “CBD” recently. Seemingly overnight, CBD is appearing everywhere from beauty product lines to burger joints. As it turns out, there’s legitimate reasoning behind “today’s” latest hype.
Epidiolex Approval Queues Up Pharmaceutical Versus Dispensary Cannabinoids Competition